Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY (PROTEGGIMI): A MULTIDIMENSIONAL RESEARCH PROJECT

NCT06177002 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06177002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06177002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY (PROTEGGIMI): A MULTIDIMENSIONAL RESEARCH PROJECT
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Unknown status
Start date
May 19, 2020
Completion date
May 18, 2025
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, infertility, male, testosterone deficiency